View Author

Hilkens, P.H.E.

( P.H.E. Hilkens)


patient neuropathy cisplatin docetaxel cancer neurotoxicity study treatment chapter trial cycle group chemotherapy symptom phase grade effect nerve cisplatin neuropathy paresthesia severity sum-score post-treatment taxotere paclitaxel combination schedule factor phase ii study agent toxicity assessment score sense method table chemotherapy-induced month tumor increase neurology vibration perception pre-treatment vecht measurement vibration perception threshold hilken metastatic breast cancer van den motor phase i breast course high-dose numbness incidence high-dose cisplatin period org 2766 evaluation oncoi number reflex examination phase ii trial metastatic post-treatment vpt value vincristine therapy corticosteroid co-medication pre-treatment vpt cessation corticosteroid paraesthesia relation dose-intensity range analysis




1 Most Recent Publications

Characteristics of Chemotherapy-induced Neuropathy: Clinical Studies on Cisplatin and Docetaxel (Doctoral Thesis)
Hilkens, P.H.E.
1998-06-17